Literature DB >> 32826638

Exercise Training Reverses Lipotoxicity-induced Cardiomyopathy by Inhibiting HMGCS2.

Shengcun Li, Xiaoli Qian, Jiahong Gong, Jie Chen, Wenzhan Tu, Xiaolong Chen, Maoping Chu1, Guanhu Yang, Lei Li1, Songhe Jiang.   

Abstract

PURPOSE: This study aimed to determine the effect of exercise training on preventing lipotoxic cardiomyopathy and to investigate the role of the 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) and miR-344g-5p in cardiomyocytes.
METHODS: Male C57BL/6 mice were fed a 60% high-fat diet (HFD) for 12 wk then began swimming exercise or remained sedentary for 8 wk. Thereafter, cardiac function was assessed by echocardiography, and heart tissue and plasma were collected for further measurements. The molecular mechanism of exercise was investigated after treating Hmgcs2 siRNA in palmitate-induced neonatal mouse cardiomyocytes.
RESULTS: HFD induced myocardial hypertrophy and fibrosis and reduced coronary reserve and cardiac function. HMGCS2 levels increased, but junctophilin-2 (JPH2) levels decreased in HFD mice hearts. Such effects were attenuated by swimming exercise. Mechanistically, Hmgcs2 silencing prevented apoptosis and caspase-3 cleavage and elevated the expression of JPH2 in palmitate-stimulated cardiomyocytes. In addition, exercise promoted miR-344g-5p expression in HFD hearts. The overexpression of miR-344g-5p by chemical mimic reduced HMGCS2, apoptosis, and caspase-3 cleavage and elevated JPH2 expression in palmitate-induced cardiomyocytes.
CONCLUSION: Our results suggest that exercise limits lipid metabolic disorder, cardiac hypertrophy, and fibrosis and aids in the prevention of lipotoxic cardiomyopathy. Exercise-mediated cardioprotection by upregulating miR-344g-5p, which targets Hmgcs2 mRNA, prohibits HMGCS2 upregulation and thus lipotoxicity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32826638     DOI: 10.1249/MSS.0000000000002453

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

Review 1.  The role of junctophilin proteins in cellular function.

Authors:  Stephan E Lehnart; Xander H T Wehrens
Journal:  Physiol Rev       Date:  2022-01-10       Impact factor: 37.312

2.  Electroacupuncture pre-treatment alleviates sepsis-induced cardiac inflammation and dysfunction by inhibiting the calpain-2/STAT3 pathway.

Authors:  Xuqing Li; Li Wang; Xinwang Ying; Yujun Zheng; Qianqian Tan; Xiaolan Yu; Jiahong Gong; Ming Li; Xiaofeng Deng; Guanhu Yang; Shengcun Li; Songhe Jiang
Journal:  Front Physiol       Date:  2022-09-07       Impact factor: 4.755

Review 3.  Animal Models of Exercise From Rodents to Pythons.

Authors:  Margaret H Hastings; Jonathan J Herrera; J Sawalla Guseh; Bjarni Atlason; Nicholas E Houstis; Azrul Abdul Kadir; Haobo Li; Cedric Sheffield; Anand P Singh; Jason D Roh; Sharlene M Day; Anthony Rosenzweig
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

4.  HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.

Authors:  Donglin Chen; Xiang Ruan; Yu Liu; Yan He
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

5.  An Effective Sodium-Dependent Glucose Transporter 2 Inhibition, Canagliflozin, Prevents Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.

Authors:  Lili He; Sai Ma; Qingjuan Zuo; Guorui Zhang; Zhongli Wang; Tingting Zhang; Jianlong Zhai; Yifang Guo
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

6.  Differential proteomic analysis of mouse cerebrums with high-fat diet (HFD)-induced hyperlipidemia.

Authors:  Changming Chen; Meiling Wen; Caixia Wang; Zhongwen Yuan; Ya Jin
Journal:  PeerJ       Date:  2022-08-03       Impact factor: 3.061

7.  Exercise inhibits JNK pathway activation and lipotoxicity via macrophage migration inhibitory factor in nonalcoholic fatty liver disease.

Authors:  Ni Cui; Hui Li; Yaoshan Dun; Jeffrey W Ripley-Gonzalez; Baiyang You; Dezhao Li; Yuan Liu; Ling Qiu; Cui Li; Suixin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.